3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Motor Activity
1
Malnutrition
1
Liver Diseases
1
Gastrointestinal Neoplasms
1
Frailty
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Breast Cancer Female
1
Interventions
Letrozole
27
Fulvestrant
27
Specimen Handling
24
ribociclib
17
pembrolizumab
16
exemestane
16
Paclitaxel
16
Carboplatin
16
Capecitabine
16
Anastrozole
16
Magnetic Resonance Spectroscopy
15
palbociclib
14
Tamoxifen
13
trastuzumab deruxtecan
12
Trastuzumab
12
Biopsy
11
abemaciclib
10
Cyclophosphamide
10
pertuzumab
8
Radiotherapy
8
elacestrant
7
sacituzumab govitecan
6
patritumab deruxtecan
6
olaparib
6
inavolisib
6
giredestrant
6
Surveys and Questionnaires
6
Radiation
6
eribulin
5
Standard of Care
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Control Groups
×
30 days
×
Clear all
NCT04816006
2026-05-20
BRAIN
Mayo Clinic
Phase NA
Recruiting
160 enrolled